PGC1α can govern carcinogenesis, progression, and metabolic status in various cancers, such as renal clear cell, prostate, endometrial, breast cancers, and melanoma, through cooperation with approximately twenty nuclear factors (PPARγ, HNF4, NRF1/2, and ERR) [17–22]. The gene discussed is PPARGC1A; the disease is breast cancer.